Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Drug Delivery Technology Market to Cross US$ 1600 Billion by 2021

Market Research Engine
Posted on: 21 Oct 16
Drug Delivery Technology Market to Cross US$ 1600 Billion by 2021

New York, October 21: Market Research Engine has published a new report titled as “Drug Delivery Technology Market by Route of Administration (Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Oral (Solid), Nasal (Drop), Topical (Solid), Implantable (Active), Transmucosal (Oral)) and by End Users (Hospital, ASC, Home Care) – Global Industry Analysis and Forecast 2016 - 2021”


How Big is the Drug Delivery Technology Market?

The Drug Delivery Technology Market is expected to exceed more than US$ 1600 Billion by 2021; Growing at a CAGR of 7.5% in the given forecast period.


Download Free Sample Report:


Drug delivery systems are engineered technologies for the targeted shipping and managed launch of healing dealers. Drug delivery is the strategy or procedure of administering a pharmaceutical compound to accomplish a remedial impact in people or animals. For the treatment of human infections, nasal and aspiratory courses of medication conveyance are increasing expanding significance. These courses give promising other options to parenteral medication conveyance especially for peptide and protein therapeutics. For this reason, a few medication conveyance frameworks have been detailed and are being examined for nasal and aspiratory conveyance. These incorporate cyclodextrins, prodrugs, gels, microspheres, proliposomes and liposomes.

The major driving factors of drug delivery technology market are as follows:

    Technological advancements and drug innovation
    Launching of the new products
    Increase in the biologics market
    Expanding prevalence of chronic disease

The drug delivery technology market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery,ocular drug delivery,topical drug delivery,transmucosal drug delivery, oral drug delivery, injectable drug delivery,nasal drug delivery andimplantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi solid and liquid. Under tropical drug delivery it covers transdermal, solid, semi solid and liquid. Transmucosal drug delivery segmentation covers oral and other. Based on oral drug delivery segmentation it covers liquid, solid and semi solid. Under injectable drug delivery segmentation it contains devices and formulations.

The drug delivery technology market is segmented on the lines of its nasal drug delivery like nasal gels, nasal powder, nasal spray and nasal drops. Under implantable drug delivery segmentation it covers passive implantable drug delivery and active implantable drug delivery. Based on end user segmentation it covers diagnostic centers, home care settings, ASCs/ clinics, hospitals and other end users.The drug delivery technology marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Browse Full Report:


This report provides:

1) An overview of the global market for drug delivery technology and related technologies.
2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.
3) Identifications of new market opportunities and targeted promotional plans for drug delivery technology.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for Drug Delivery Technology with the reasons given for variations in the growth of the industry in certain regions.

The report mentions the detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche (Switzerland),Pfizer, Inc. (U.S.),  Johnson & Johnson Services Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany). Company profile includes details such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Drug delivery technology Market has been segmented as below:  

By Route of Administration Analysis

Pulmonary drug delivery

    Dry powder inhaler
    Metered dose inhaler

Ocular drug delivery
    Ocular devices
    Semi solid

Topical drug delivery
    Semi solid

Transmucosal drug delivery

Oral drug delivery
    Semi solid

Injectable drug delivery

Nasal drug delivery
    Nasal gels
    Nasal powder
    Nasal spray
    Nasal drops

Implantable drug delivery
    Passive implantable drug delivery
    Active implantable drug delivery

By End-user Analysis

Diagnostic centers
Home care settings
ASCs/ Clinics
Other end users

By Regional Analysis

North America
Rest of the World

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 21/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.